The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D07 | Corticosteroids, dermatological preparations | |
| 3 | D07A | Corticosteroids, plain | |
| 4 | D07AD | Corticosteroids, very potent (group IV) |
| Code | Title | |
|---|---|---|
| D07AD01 | Clobetasol | |
| D07AD02 | Halcinonide |
| Active Ingredient | Description | |
|---|---|---|
| Clobetasol propionate |
Clobetasol propionate, like other topical corticosteroids, has anti-inflammatory, antipruritic, and vasoconstrictive properties. Corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. |
|
| Halcinonide |
Halcinonide is a topical corticosteroid. Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity is unclear. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| CLARELUX Cutaneous foam | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| CLODERM Cream | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| DERMOVATE Scalp application | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ETRIVEX Shampoo | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| MEDODERMONE Cream | Υπουργείο Υγείας (CY) | MPI, EU: SmPC |
